Ionis Pharmaceuticals | IONS - 营业费用



金融业
股票价格
USD 41.24
资产
USD 2.99B
现金及等价物
USD 350.07M
销售成本
USD 2.74M
流动资产
USD 2.49B
流动负债
USD 315.64M
债务
USD 1.91B
EBIT
USD -102.29M
EBITDA
USD -64.53M
员工
1.07K
EPS每股收益
USD -0.69
股本和储备
USD 439.74M
销售毛利
USD 265M
债务利息支出
USD 18M
利息收入
USD -0.66
贷款资金
USD 1.91B
市值
USD 6.33B
净收入
USD -114.65M
营业费用
USD 370.24M
营业利润
USD -102.29M
普通股股本
USD 165.64M
PE价格收益
396.15
税前利润
USD -114M
销售收入
USD 268M
销售和管理费用
USD 130.08M
股票
USD 50.83M
贸易债权人
USD 47.7M
应收帐款人
USD 58.85M


营业费用 更改 日
Agios Pharmaceuticals USD 130.77M 10.77M 2026-03
Alnylam Pharmaceuticals USD 1.11B 52.78M 2026-09
Arrowhead Research USD 245.35M 30.35M 2026-06
Astellas Pharma JPY 455.56B 33.8B 2026-06
BioCryst Pharmaceuticals USD 119.78M 673.63M 2026-06
BioMarin Pharmaceutical USD 6.32B 5.69B 2026-06
Celltrion KRW 133.99B 14.77B 2026-06
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
Deva Holding AS TRY 1.35B 178.26M 2023-09
Divis Laboratories Ltd INR 19.51B 660M 2026-06
Exelixis USD 390.27M 10M 2026-09
Halozyme Therapeutics USD 193.34M 1.15M 2026-06
Ionis Pharmaceuticals USD 370.24M 6.24M 2026-06
Kangmei Pharma CNY 1.22B 130.32M 2026-06
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Moderna USD 960M 817M 2026-06
Nektar Therapeutics USD 49.12M 8.22M 2026-03
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Neurocrine Biosciences USD 739.1M 139.2M 2026-06
Novartis USD 9.88B 325M 2026-09
Omeros USD 59.16M 20.13M 2024-06
OPKO Health USD 188.62M 13.41M 2026-06
Organigram Holdings CAD 100.45M 30.86M 2026-06
Ovoca Bio EUR 173K 990K 2025-12
Pfizer USD 85.19B 4.91B 2026-06
Pharma Mar EUR 46.77M 4.24M 2026-09
PTC Therapeutics USD 211.54M 15.12M 2026-06
Qiagen NV USD 393.64M 17.95M 2026-06
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09
Roche Holding CHF 18.9B 2.12B 2026-06
Sarepta Therapeutics USD 387.96M 15.59M 2026-06
Sartorius EUR 746.5M 1.3M 2026-09
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Tilray USD 237.52M 17.34M 2025-09
Ultragenyx Pharmaceutical USD 289M 16M 2026-06
Vertex Pharmaceuticals USD 2.07B 217.1M 2026-06
Zealand Pharma A/S 573M 202.97M 2026-03
Zz Pientze Pharmaceu CNY 1.54B 90.74M 2026-09